succinylated gelatin Injection 20 mg - 500 ml
Dossier type
CTD
Dossier status
Ready to file
Country of origin
China
GMP approvals
China
Unavailable markets
China
Registered in
China
Manufacturer #22188
Founded in 1999, this diversified pharmaceutical group has over two decades of R&D and multi-platform manufacturing expertise in small molecules and biologics. Rx portfolio targets oncology, metabolic, and cardiovascular diseases in solid, injectable, and biologic dosage forms. Advances innovative candidates through global licensing partnerships with multinational pharmaceutical companies.
Manufacturer usually replies in 13 days